Related Experiment Video

Updated: May 31, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis

Sameer R Oak1, Lynne Murray, Athula Herath

  • 1Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.

Plos One
|June 30, 2011
PubMed
Abstract

Insights

Differential microRNA (miRNA) expression may explain varying idiopathic pulmonary fibrosis (IPF) progression rates. Aberrant miRNA processing, impacting epithelial-mesenchymal transition, is implicated in rapid IPF development and progression.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Genomics

Background:

  • Idiopathic pulmonary fibrosis (IPF) progression varies significantly between patients.
  • The molecular mechanisms underlying differential IPF progression remain unclear.
  • MicroRNA (miRNA) dysregulation is a potential factor in IPF pathogenesis.

Purpose of the Study:

  • To investigate if differential miRNA expression explains rapid versus slow IPF progression.
  • To identify specific miRNAs associated with IPF disease course.
  • To explore the role of miRNA processing in IPF.

Main Methods:

  • Quantitative PCR miRNA array profiling of lung biopsies from rapid IPF, slow IPF, and normal controls.
  • Isolation of miRNA and mRNA from surgical lung biopsies.
  • Analysis of miRNA targets, including those involved in epithelial-mesenchymal transition (EMT).

Main Results:

  • Significant differences in miRNA expression were observed between rapid IPF, slow IPF, and normal lung tissues.
  • Five specific miRNAs (miR-302c, miR-423-5p, miR-210, miR-376c, and miR-185) were elevated in rapid IPF compared to slow IPF.
  • Lower expression of AGO1 and AGO2, key components of the miRNA processing RISC complex, was found in rapid IPF biopsies.

Conclusions:

  • Aberrant miRNA processing is suggested to play a role in the development and/or clinical progression of IPF.
  • Specific miRNA signatures may differentiate rapid from slow IPF.
  • Targeting miRNA processing could be a therapeutic strategy for IPF.

More Related Videos

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice07:38

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

Published on: April 13, 2018

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...